Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119346) titled 'Analysis of Risk Factors and Construction of a Predictive Model for Grade 3 and Above Adverse Reactions Related to Adjuvant Therapy after Surgery for Early Breast Cancer' on Feb. 26.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated Hospital of the Baotou Medical College of Inner Mongolia University of Science and Technology
Condition:
Breast cancer
Intervention:
Grade =3 Adverse Reaction Group:75;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=311371
Published by HT Digital Content Services with permissio...